Tennessee · 114th Regular Session (2025-2026) · Bill

SB 1848: Controlled Substances - As enacted, authorizes additional healthcare providers to directly administer buprenorphine mono or buprenorphine without the use of naloxone; adds that prescribing a buprenorphine product to nursing mother or prescribing an injectable mono product does not restrict certain healthcare providers from prescribing a buprenorphine product for the treatment of opioid use disorder without naloxone. - Amends TCA Title 53, Chapter 11.

In committee Last action April 24, 2026: Comp. became Pub. Ch. 753

Plain-language summary

SB 1848 is a bill introduced in the Tennessee Senate on January 21, 2026. According to its official title, it concerns: Controlled Substances - As enacted, authorizes additional healthcare providers to directly administer buprenorphine mono or buprenorphine without the use of naloxone; adds that prescribing a buprenorphine product to nursing mother or prescribing an injectable mono product does not restrict certain healthcare providers from prescribing a buprenorphine product for the treatment of opioid use disorder without naloxone. - Amends TCA Title 53, Chapter 11. Primary sponsor: Becky Massey (Republican). Most recent recorded action (April 24, 2026): Comp. became Pub. Ch. 753.

Sponsors

Primary sponsor: Becky Massey (Republican).